Related references
Note: Only part of the references are listed.Quantitative Analysis of Transthyretin, Tau and Amyloid-β in Patients with Dementia
Sara Friederike Gloeckner et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
Weiming Xia et al.
ARCHIVES OF NEUROLOGY (2009)
Cytoplasmic gelsolin increases mitochondrial activity and reduces Aβ burden in a mouse model of Alzheimer's disease
Desiree Antequera et al.
NEUROBIOLOGY OF DISEASE (2009)
Developing a simple laboratory test for Alzheimer's disease: measuring acetylcholinesterase in saliva - a pilot study
Paul F. Boston et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Megalin mediates the transport of leptin across the blood-CSF barrier
Marcelo O. Dietrich et al.
NEUROBIOLOGY OF AGING (2008)
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Sandip Ray et al.
NATURE MEDICINE (2007)
No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2007)
Serum biomarkers for Alzheimer's disease: Proteomic discovery
Dwight C. German et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Effect of γ-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells
Young S. Oh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Tissue kallikrein mK13 is a candidate processing enzyme for the precursor of interleukin-1β in the submandibular gland of mice
CJ Yao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment
K Blennow
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors
R Sayer et al.
CLINICAL BIOCHEMISTRY (2004)
Back to the future: the 'old-fashioned' way to new medications for neurodegeneration
PT Lansbury
NATURE MEDICINE (2004)
Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse
EJH Lehman et al.
HUMAN MOLECULAR GENETICS (2003)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease
T Sunderland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease
LE Goldstein et al.
LANCET (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Rapid noninvasive measurement of hormones in transdermal exudate and saliva
CJ Cook
PHYSIOLOGY & BEHAVIOR (2002)
Accumulation of amyloid-β protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor
KI Fukuchi et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2000)
Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils
I Ray et al.
BRAIN RESEARCH (2000)
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
PD Mehta et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
